111 related articles for article (PubMed ID: 28301380)
1. Nitroxoline shows antimyeloma activity by targeting the TRIM25/p53 axle.
Mao H; Du Y; Zhang Z; Cao B; Zhao J; Zhou H; Mao X
Anticancer Drugs; 2017 Apr; 28(4):376-383. PubMed ID: 28301380
[TBL] [Abstract][Full Text] [Related]
2. TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer.
Takayama KI; Suzuki T; Tanaka T; Fujimura T; Takahashi S; Urano T; Ikeda K; Inoue S
Oncogene; 2018 Apr; 37(16):2165-2180. PubMed ID: 29379164
[TBL] [Abstract][Full Text] [Related]
3. Nitroxoline induces cell apoptosis by inducing MDM2 degradation in small-cell lung cancer.
Yu JG; Ji CH; Shi MH
Kaohsiung J Med Sci; 2019 Apr; 35(4):202-208. PubMed ID: 30896891
[TBL] [Abstract][Full Text] [Related]
4. JP3, an antiangiogenic peptide, inhibits growth and metastasis of gastric cancer through TRIM25/SP1/MMP2 axis.
Chen JJ; Ren YL; Shu CJ; Zhang Y; Chen MJ; Xu J; Li J; Li AP; Chen DY; He JD; Shu YQ; Zhou JW
J Exp Clin Cancer Res; 2020 Jun; 39(1):118. PubMed ID: 32576271
[TBL] [Abstract][Full Text] [Related]
5. Knockdown of TRIM32 inhibits tumor growth and increases the therapeutic sensitivity to temozolomide in glioma in a p53-dependent and -independent manner.
Cai Y; Gu WT; Cheng K; Jia PF; Li F; Wang M; Zhang WF; Qiu JT; Wu ZB; Zhao WG
Biochem Biophys Res Commun; 2021 Apr; 550():134-141. PubMed ID: 33691199
[TBL] [Abstract][Full Text] [Related]
6. TRIM25 promotes the cell survival and growth of hepatocellular carcinoma through targeting Keap1-Nrf2 pathway.
Liu Y; Tao S; Liao L; Li Y; Li H; Li Z; Lin L; Wan X; Yang X; Chen L
Nat Commun; 2020 Jan; 11(1):348. PubMed ID: 31953436
[TBL] [Abstract][Full Text] [Related]
7. TRIM25 has a dual function in the p53/Mdm2 circuit.
Zhang P; Elabd S; Hammer S; Solozobova V; Yan H; Bartel F; Inoue S; Henrich T; Wittbrodt J; Loosli F; Davidson G; Blattner C
Oncogene; 2015 Nov; 34(46):5729-38. PubMed ID: 25728675
[TBL] [Abstract][Full Text] [Related]
8. The ubiquitin ligase TRIM25 targets ERG for degradation in prostate cancer.
Wang S; Kollipara RK; Humphries CG; Ma SH; Hutchinson R; Li R; Siddiqui J; Tomlins SA; Raj GV; Kittler R
Oncotarget; 2016 Oct; 7(40):64921-64931. PubMed ID: 27626314
[TBL] [Abstract][Full Text] [Related]
9. TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.
Qin X; Qiu F; Zou Z
Biochem Biophys Res Commun; 2017 Nov; 493(1):568-572. PubMed ID: 28867193
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression.
Qin Y; Cui H; Zhang H
Technol Cancer Res Treat; 2016 Oct; 15(5):707-15. PubMed ID: 26113559
[TBL] [Abstract][Full Text] [Related]
11. Identification of TRIM25 as a Negative Regulator of Caspase-2 Expression Reveals a Novel Target for Sensitizing Colon Carcinoma Cells to Intrinsic Apoptosis.
Nasrullah U; Haeussler K; Biyanee A; Wittig I; Pfeilschifter J; Eberhardt W
Cells; 2019 Dec; 8(12):. PubMed ID: 31842382
[TBL] [Abstract][Full Text] [Related]
12. The role of Trim25 in development, disease and RNA metabolism.
Heikel G; Choudhury NR; Michlewski G
Biochem Soc Trans; 2016 Aug; 44(4):1045-50. PubMed ID: 27528750
[TBL] [Abstract][Full Text] [Related]
13. Tripartite motif containing 25 promotes proliferation and invasion of colorectal cancer cells through TGF-β signaling.
Sun N; Xue Y; Dai T; Li X; Zheng N
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28620119
[TBL] [Abstract][Full Text] [Related]
14. The E3 Ligase TRIM25 Impairs Apoptotic Cell Death in Colon Carcinoma Cells via Destabilization of Caspase-7 mRNA: A Possible Role of hnRNPH1.
Nasrullah U; Stanke K; Recknagel V; Bozkurt S; Wurzel P; Gauer S; Imre G; Münch C; Pfeilschifter J; Eberhardt W
Cells; 2023 Jan; 12(1):. PubMed ID: 36611995
[TBL] [Abstract][Full Text] [Related]
15. All Paths Lead to TRIM25.
Zhou H; Costello JC
Trends Cancer; 2017 Oct; 3(10):673-675. PubMed ID: 28958384
[TBL] [Abstract][Full Text] [Related]
16. p53 Cooperates berberine-induced growth inhibition and apoptosis of non-small cell human lung cancer cells in vitro and tumor xenograft growth in vivo.
Katiyar SK; Meeran SM; Katiyar N; Akhtar S
Mol Carcinog; 2009 Jan; 48(1):24-37. PubMed ID: 18459128
[TBL] [Abstract][Full Text] [Related]
17. An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis.
Walsh LA; Alvarez MJ; Sabio EY; Reyngold M; Makarov V; Mukherjee S; Lee KW; Desrichard A; Turcan Ş; Dalin MG; Rajasekhar VK; Chen S; Vahdat LT; Califano A; Chan TA
Cell Rep; 2017 Aug; 20(7):1623-1640. PubMed ID: 28813674
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of TRIM25 mediated ubiquitination of metastasis associated protein (MTA) 1 in normal liver cells.
Li YH; Zhong M; Zang HL; Tian XF
Exp Cell Res; 2018 Oct; 371(1):250-254. PubMed ID: 30118695
[TBL] [Abstract][Full Text] [Related]
19. 14-3-3 scaffold proteins mediate the inactivation of trim25 and inhibition of the type I interferon response by herpesvirus deconjugases.
Gupta S; Ylä-Anttila P; Sandalova T; Sun R; Achour A; Masucci MG
PLoS Pathog; 2019 Nov; 15(11):e1008146. PubMed ID: 31710640
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of p38alpha MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-X(L), Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo.
Navas TA; Nguyen AN; Hideshima T; Reddy M; Ma JY; Haghnazari E; Henson M; Stebbins EG; Kerr I; O'Young G; Kapoun AM; Chakravarty S; Mavunkel B; Perumattam J; Luedtke G; Dugar S; Medicherla S; Protter AA; Schreiner GF; Anderson KC; Higgins LS
Leukemia; 2006 Jun; 20(6):1017-27. PubMed ID: 16617327
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]